After the initial buzz around its June 2024 IPO, Raspberry Pi (RPI) seemed to be getting a few raspberries from the market as the shares drifted from their early highs.However, over the last month the stock has advanced more than 40% to trade at record levels.Founded by chief executive Eben Upton in 2012 with the premise of making computing 'more accessible to young people', Raspberry Pi designs a

European stocks were down at midday in London, as new economic data from China showed continued sluggish domestic consumption.China's retail sales growth weakened last month, official data showed on Monday, missing forecasts as demand remains muted in the world's number two economy. Retail sales expanded 3% year-on-year in November, the National Bureau of Statistics said, slowing from a 4.8% rise

Softer than expected Q3Gross margins to remain stableGrowth slows ahead of ChristmasSpanish clothing retailer Inditex (ITX:BME) has transformed itself from a humble textile maker into a global fashion titan with a reputation for being on-trend and quick to market and can usually be relied upon to meet or beat forecasts.But the Madrid-listed shares were under pressure on 11 December, falling 5% to

The potential appointment of well-known vaccine sceptic Robert F Kennedy Jnr to the Trump cabinet in the role of head of the Department of Health and Human Services sent shivers through pharmaceutical companies on 14 November, with shares falling around 7% on average on both sides of the Atlantic.Kennedy has previously cast doubts on the Covid-19 vaccine, describing it as 'the deadliest vaccine ev

International Biotechnology Trust (IBT) 716pMarket cap: £263.2 millionWarren Buffett tells investors to be greedy when others are fearful and take advantage of depressed prices. That in a nutshell is the investment proposition for International Biotechnology Trust (IBT), which sits on an 11% discount to NAV (net asset value).The discount is not quite as extreme as it was when we highlighted the t

Gold has had a great year. Spot prices hit another all-time high (30 October) of $2,781 per ounce, based on Bloomberg data, chalking up 35% gains so far in 2024, having broken through the $2,600 level in September for the very first time.That trumps global equities, based on the FTSE World Index's 18% returns, and even high-flying tech firms have struggled to keep pace, based on the 27% year-to-da

Shares up 9% to £51.08Reckitt's baby formula business Mead Johnson clearedMead Johnson bought by Reckitt in 2017Shares in Reckitt Benckiser (RKT) skyrocketed on Friday morning after its US baby formula business Mead Johnson was cleared of liability in a US trial linking the consumer goods group's premature-baby formula Enfamil to bowel disease.A state court in St Louis, Missouri on 31 October rej

Equity markets are buoyant, fixed income markets seem more nervous judging by the way yields are rising (at least for government-issued in the developed West), and commodity prices continue to march to their own beat, with gold and silver surging, industrial metals largely flat and oil and gas remaining subdued.The relative calm pervading hydrocarbon prices is in many ways surprising, given the on

Blue chip stocks in the UK, France and Germany opened higher on Monday morning, but shares in London-listed oil majors BP and Shell fell alongside the price of Brent.The FTSE 100 index opened up 13.33 points, 0.2%, at 8,262.17. The FTSE 250 was up 89.53 points, 0.4%, at 20,909.44, and the AIM All-Share was up 1.81 points, 0.3%, at 724.48.The Cboe UK 100 was up 0.2% at 827.28, the Cboe UK 250 rose

There is a huge body of academic work highlighting behavioural biases which consistently trip-up investors' supposedly rational thinking. In this article we look at seven big sins of investing, with some examples and insights on how to avoid them.A lot of the credit for these principles goes to Daniel Kahneman and Amos Tversky who collaborated in the 1960s to research apparent anomalies and contra

The FTSE 100 opened in the red on Wednesday morning, but other London stocks were mostly in the green, as investors awaited home sale and building permit data from the US.'An incredibly quiet economic calendar awaits today,' observed Pepperstone's Michael Brown, 'with only August's new home sales figures of note, though today's five-year auction will attract some attention after solid demand for y

HVIVO (HVO:AIM) 28.2pMarket cap: £191.9 millionFluCamp does not sound like much fun for volunteers, but for leading CRO (contract research organisation) HVIVO (HVO:AIM) it represents a flagship service which is attracting growing interest from big pharma and biotechnology companies.The company is at the forefront of HCTs (human challenge trials), a fast-growing niche within the large CRO industry

Anniversaries are often an opportunity to take stock so the Shares team has had a look at the best performing shares, funds and investment trusts since the magazine's first issue in September 1999.Read on to discover the identity of the top performers and find out names we think will continue to impress in the years to come and those where we think the good times might be over. But first, Ian Conw

Diversified food multinational General Mills (GIS:NYSE), which makes and markets breakfast cereals Cheerios and Lucky Charms, has a well-deserved reputation as a resilient total return stock. The company reinvests its reliable cash flows behind its brands whilst returning cash to shareholders through dividends and buybacks.Shares in the meal, snack and baking mix supplier have rebounded strongly s

It's said there are only two certainties in life ? death and taxes ? and as it stands the world is steadily getting older, with not enough births or young people coming through to offset the increasing ranks of the middle-aged and old-aged.Moreover, according to the United Nations' latest World Populations Prospects study which came out earlier this year, the global population is likely to peak th

Stocks in London drifted into the red on Monday, on what was a quieter day for global equity markets given the US public holiday.The FTSE 100 index closed down 12.79 points, 0.2%, at 8,363.84. The FTSE 250 ended down 106.03 points, 0.5%, at 20,980.51, and the AIM All-Share closed down 5.61 points, 0.7%, at 766.90.The Cboe UK 100 ended down 0.1% at 836.73, the Cboe UK 250 closed down 0.4% at 18,493

Stocks in London ended in the red on Wednesday, as the market eagerly awaited the earnings from chipmaker and AI-play Nvidia.The FTSE 100 index ended down just 1.61 points at 8,343.85. The FTSE 250 declined 95.20 points, or 0.5%, at 21,066.87, and the AIM All-Share closed down 8.88 points, or 1.1%, at 770.30.The Cboe UK 100 ended down 0.1% at 834.14, the Cboe UK 250 fell 0.4% at 18,566.65, and the

Delaware court agrees to reviewHepatitis B drug gets fast track approvalNucala approval in JapanBiopharma giant GSK (GSK) was one of the top gainers in the FTSE today, rising 2% to £16.47 after releasing positive drug updates and news that the Delaware Supreme court has agreed to review its prior decision to allow expert witnesses in the ongoing Zantac litigation cases.The shares have advanced ar

Stock prices in London were mixed at Midday Monday, with fintech Plus500 in the FTSE 250 enjoyed a boost after reporting a profit rise and a share buyback programme.The FTSE 100 index was down just 3.61 points at 8,307.80. The FTSE 250 was up 22.16 points, 0.1%, at 21,071.07, and the AIM All-Share was down 1.43 points, 0.2%, at 775.70.The Cboe UK 100 was down 0.1% at 829.91, the Cboe UK 250 was up

The FTSE 100 ended a stormy week in calmer fashion after data allayed fears of an impending economic slowdown.After the turmoil following last week's US nonfarm payrolls print, this week closed on a more muted note than it had started. Lower-than-expected US jobless claims on Thursday, and robust US services PMIs earlier in the week, helped to quell anxiety that the US economy had weakened more ra